Better AI Chip Stock to Buy Today: Broadcom vs. Marvell
Axe Cap view
Broadcom Beats Marvell for AI Chip Leadership
Broadcom’s dominant position in AI chip design and cheaper valuation make it a better buy than Marvell despite Marvell’s share rally.
AI’s infrastructure build-out is forcing rapid chip innovation, and Broadcom stands out with a projected 60% market share in AI ASICs by 2026. Its ties with big players like Alphabet and Anthropic offer stability that Marvell lacks. Marvell’s 200% share price jump this year already prices in high growth at a steep 25x forward P/E, making it vulnerable if the AI momentum slows. Meanwhile, Broadcom’s 11.5x forward P/E shows more value and less risk. For South African investors, where tech exposure on the JSE is mostly through Naspers and Prosus, Broadcom’s cheaper valuation might temper further downside risk in the USD/ZAR should global tech cool. However, risks include a sudden slowdown in hyperscaler AI spending or tech supply chain setbacks that could crimp Broadcom’s outlook. this is just our opinion and not financial advice
Buy Broadcom for exposure to AI chip demand with a focus on value; trim or avoid Marvell given its stretched valuation. Consider USD/ZAR hedging if global tech volatility spikes.
- AVGO
- MRVL
- USD/ZAR
- Hyperscaler AI spending slows unexpectedly
- Global supply chain disruptions hit chip production
7/10
Broadcom and Marvell are both leaders in custom AI chip design and data center networking, benefiting from the AI infrastructure build-out wave. While Marvell stock has outperformed significantly this year (up 200% vs. Broadcom's 3%), Broadcom is recommended as the better buy due to its market leadership in AI ASIC design (60% projected market share), premium customer base including Alphabet and Anthropic, and significantly cheaper valuation (P/E of 11.5x vs. Marvell's 25x for comparable periods).
Our take is based on reporting first published by The Motley Fool.
More stories like this
- Nokia Oyj vs. AT&T: Which Technology Stock Is a Better Buy in 2026?
- Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?
- Bill Ackman Just Said 4 Words Blasting the Fed's Latest Rate Hike: "Just Made a Mistake." Here's Why He Thinks Higher Rates Could Backfire on AI-Driven Inflation.